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Abstract 
 
Recent research emphasizes the contribution of environmental as well as genetic factors to the 
etiology of autism but studies testing associations between chemical exposures and autism have 
been limited. Prenatal exposure to persistent organic pollutants (POPs) has previously been 
associated with decrements in cognitive and developmental performance. We conducted a pilot 
study in the Finnish Prenatal Study of Autism (FiPS-A). Seventy-five cases with autism and 75 
controls matched on sex, birth year, urbanization and maternal age were sampled from first-born 
children in the Finnish Maternity Cohort, which includes over 1 million births. The study sample 
included births occurring from 1991 to 2000.  Subjects were followed up for autism through 
2007. DDT, DDE, PCB-118, PCB-138, PCB-153, PCB-156, PCB-170, PCB-180, 
hexachlorobenzene, and BDE-47 were measured in archived maternal serum samples taken 
during pregnancy using gas chromatography-high resolution mass spectrometry. Correlations 
between pollutant measures were assessed and mechanistically-related weighting schemes for 
summarizing PCB levels were compared. Case and control differences were assessed using 
graphical and statistical methods. All analytes, with the exception of DDT and BDE-47, were 
detected above the limit of quantification in all samples.  The correlation between levels of 
individual PCB congeners and weighted summary measures was high (0.71-1.00). Paired t-tests 
revealed no significant differences between cases and controls for log-transformed mean values 
of any analyte; however, in an adjusted model the odds ratio for autism was 1.91 (p=0.29) and 
1.79 (p= 0.36) respectively, for subjects with total PCBs and DDE above the 90
th
 percentile of 
control values. Levels of prenatal PCB exposure in FIPS-A were similar to levels previously 
correlated with poorer neurodevelopmental measures in other populations. Further study in a 
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larger sample will be required to fully determine whether exposure to high POP levels are 
associated with autism diagnosis in the population.  
Keywords: autism, persistent organic pollutants, PCBs, DDE, prenatal 
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1. Introduction 
Autism is a developmental disorder involving impairments in language and social interaction; 
repetitive behaviors and restricted interests; and with an onset before age three. The 
developmentally dependent nature of the deficits involved in autism means that diagnosis is not 
typically made until after the first year of life. However, evidence suggests that 
neurodevelopmental events underlying the behavioral characteristics of autism have roots in the 
prenatal period (Arndt et al., 2005; Patterson, 2009), while recent heritability estimates suggest 
that environmental factors, in concert with genetics, play a substantial role in risk for the disorder 
(Hallmayer et al., 2011). Studies are limited in number that have addressed potential associations 
between autism spectrum disorders (ASDs) and prenatal exposure to chemicals in the 
environment, primarily focusing on exposure via air (Windham et al., 2006; Kalkbrenner et al., 
2010; Roberts et al., 2007; Larsson et al., 2009; Volk et al., 2011). 
Persistent organic pollutants (POPs) such as polychlorinated biphenyls (PCBs), 
polybrominated diphenyl ether (PBDE), the pesticide dichlorodiphenyltrichloroethane 
(DDT), and its metabolite (dichlorodiphenyldichloroethylene) DDE, are lipophilic and 
bioaccumulate in the food chain. Associations between prenatal PCB or DDT/DDE 
exposure and lower scores on neurodevelopmental measures in humans have been 
reported in some (i.e. (Eskenazi et al., 2006; Jacobson and Jacobson, 1996; Jacobson and 
Jacobson, 2003; Jacobson et al., 1985; Park et al., 2010; Patandin et al., 1999; Stewart et 
al., 2000; Stewart et al., 2008; Torres-Sanchez et al., 2007)), though not all (i.e. (Bahena-
Medina et al., 2011; Fenster et al., 2007; Gray et al., 2005; Winneke et al., 1998)) studies. 
While associations reported have primarily focused on general developmental or cognitive 
measures, studies examining biomarkers of exposure to PCBs, DDT or PBDE, 
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specifically, and autism have not to our knowledge been reported. Roberts et al. reported 
an increased risk of ASD among children whose mothers lived near sites where 
organochlorine pesticides as a group had been applied to fields in California during 
gestation (Roberts et al., 2007). Dicofol and endosulfan were the two pesticides primarily 
accounting for applications in this category. Dicofol in particular is chemically similar to 
DDT but is cleared from the body more quickly with lower bioaccumulation (Roberts et 
al., 2007). It may be hypothesized, therefore, that DDT could have a similar, and perhaps 
stronger, association with autism.  
The Finnish Prenatal Study of Autism (FiPS-A) is based on a national birth cohort 
including the approximately 1.2 million births in Finland occurring from 1987-2005. A unique 
feature is availability of archived maternal serum samples taken during early gestation.  A study 
of 112 placentae from male infants born between 1997-2001 in Finland found detectable levels 
of p,p’-DDE in 100% of samples, as well as a high prevalence of additional organochlorinated 
pesticides (Shen et al., 2005), suggesting that prenatal exposure to these substances is relevant 
for the Finnish population. We conducted a pilot study with the following aims: 1) to establish 
the feasibility of measuring POPs in prenatal maternal serum samples from the FiPS-A; 2) to 
evaluate associations of POPs with covariates in the general population; 3) to compare 
alternative weighting schemes for PCB congeners; and 4) to assess preliminary evidence for a 
relationship between exposure to prenatal POPs and autism.  
 
2. Methods  
2.1. Population 
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Complete details of the FiPS-A study design have been published elsewhere (Lampi et al., 2011). 
Briefly, the FiPS-A is based on the Finnish Maternity Cohort, a large national birth cohort 
including the approximately 1.2 million births in Finland from 1987-2005. We identified 1,132 
childhood autism (ICD-code F84.0) cases diagnosed through 2007 by record linkage of the 
Finnish Medical Birth Registry (FMBR) with the Finnish Hospital and Outpatient Discharge 
Registry. Finnish registry diagnoses of childhood autism have been validated by the ADI-R, with 
77/80 cases assessed (96%) meeting ICD-10 criteria (Lampi et al., 2010). Controls from the 
FMBR without ASD or severe/profound mental retardation were matched 4:1 to cases on date of 
birth (+/- 30 days), sex, place of birth, and residence in Finland. One control per case was 
selected for serologic analysis. Data on additional pre-, peri-, and neonatal variables are available 
from the FMBR.  
 For the present study, 75 subjects with autism and 75 controls matched on sex, birth year, 
urbanization and maternal age were selected from the total FiPS-A population. The purpose of 
matching was to select a comparison group similar on potential confounders given the limited 
sample size. The study sample was selected from first-born children born from 1991 to 2000 
with sera available for analysis. For 66/75 case-control pairs a match according to these criteria 
was found from among the 4 matched controls identified for the parent study; for 9 pairs, a 
control meeting matching and inclusion criteria for the current study was identified from among 
other FiPS-A control subjects. Among 146 subjects where gestational age at blood draw was 
known, 79% of maternal samples were collected during the first trimester. Mean gestational age 
at blood draw did not significantly differ (p=0.70) between cases (11.1 weeks) and controls (10.8 
weeks). 
2.2. Laboratory analysis 
8 
 
DDT, DDE, 2,3',4,4',5-pentachlorobiphenyl (PCB-118), 2,2',3',4,4',5-hexachlorobiphenyl (PCB-
138), 2,4,5,2',4',5'-hexachlorobiphenyl (PCB-153), 2,3,3',4,4',5-hexachlorobiphenyl (PCB-156), 
2,2',3,3',4,4',5-heptachlorobiphenyl (PCB-170), 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB-180), 
hexachlorobenzene (HCB), and 2,2’,4’4’-tetrabromodiphenyl ether (BDE-47) were measured in 
200 µl aliquots from archived maternal serum using an extension (Koponen et al, manuscript 
under preparation) of previously published methods (Rantakokko et al., 2009). POPs selected for 
measurement were based on previous association with neurodevelopmental outcomes, 
environmental impact, and technical capabilities of the assay. The 6 PCB congeners measured 
account for approximately 80% of total PCBs on a mass basis. Briefly, after thawing the 
samples, ethanol and 
13
C-labelled internal standards of each compound were added to serum to 
precipitate the proteins and equilibrate internal standards. Dichloromethane-hexane and activated 
silica were added and samples mixed. In this step extraction of POPs to organic solvent and 
binding of the sample water, ethanol and precipitate to activated silica were performed 
simultaneously. The upper dichloromethane-hexane layer was poured into a Solid Phase 
Extraction cartridge (SPE cartridge) containing silver nitrate silica and a mixture of sodium 
sulphate and silica. The lower semisolid layer in the test tube was extracted again with 
dichloromethane-hexane, and solvent was poured into the same SPE-cartridge. Elution of the 
SPE-cartridge was continued using additional dichloromethane-hexane. The eluate was 
concentrated to 20-30 µl and analyzed with gas chromatography (Agilent 6890) high resolution 
mass spectrometry (Waters Autospec Ultima). 
 In each batch of samples, 2 blanks were included, to control for possible laboratory 
contamination. Two control samples, Standard Reference Material 1589a (PCBs, Pesticides, 
PBDEs, Dioxins/Furans in human serum), from the National Institute of Standards and 
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Technology were included in each batch. Average recoveries of measured POPs in SRM 1589a 
were 92.5-104.8% of the certified values. The relative standard deviation of results measured 
from SRM 1589a ranged from 2.5 to 5.0% for all compounds except for p,p’-DDT for which it 
was 14.4% due to levels in SRM 1589a close to the limit of quantitation of the method. 
 
2.3. Weighting schemes 
PCBs have different modes of action with potential relevance for autism both within and across 
congeners. Because it is not precisely known which type of toxicity would be potentially most 
relevant for autism, we compared four different summary measures for PCBs: a sum of the total 
concentrations of the 6 measured congeners (“total PCBs”) and three previously published 
weighting schemes: toxic equivalents (TEQ) for dioxin-like PCBs (Van den Berg et al., 2006), 
neurotoxic equivalent (NEQ) based on in vitro measures such as Ca
+2
 homeostasis (Simon et al., 
2007) and a thyroid-hormone based TEQ (Yang et al., 2010).  
2.4. Statistical analysis 
Characteristics (birth year, maternal and paternal ages, sex, urbanicity, previous maternal 
pregnancies, and maternal socioeconomic status) of cases and controls were tabulated and 
compared using chi-square tests. To test for association of exposure with covariates in the 
general population which could potentially lead to confounding, means and standard deviations 
of the natural log of pollutant levels were calculated by category of covariates in controls, and 
differences across categories tested using ANOVA (f-test) and tests of linear trend.  
Quantile-quantile (Q-Q) plots were used to graphically compare case and control 
distributions of pollutant levels. POP measures were log-transformed prior to statistical analyses. 
Means for each POP measure were compared between cases and matched controls using paired t-
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tests. Correlations between individual pollutant measures and summary measures were 
calculated.  
Because univariate and graphical comparisons suggested no differences in case and 
control distributions near the middle of the exposure range, but possible differences at the high 
end of the range, conditional logistic regression models used indicator variables for at or above 
(versus below) the 90
th
 percentile of control values for pollutants. Conditional logistic regression 
models were used to examine the associations between childhood autism and each POP measure. 
Unadjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated for each POP 
measure. Due to high correlation (described below) between PCB congeners and summary 
measures, total PCBs were used as a single measure of PCB exposure in a multivariate model 
that also included DDE and HCB. DDT and BDE-47 were not included due to high numbers of 
observations with missing data. In all analyses, a two-sided p-value of <0.05 was considered 
statistically significant. Statistical analyses were performed with SAS statistical software (SAS 
Version 9.2, Cary, NC, USA). 
 
3. Results 
Birth year, parental ages, sex and urbanicity were similar for control and autism groups (Table 
1). Autism mothers were more likely to have experienced a prior pregnancy and to have an upper 
white collar or “other” socioeconomic status, but these differences were not statistically 
significant (p>0.05).  
For all 6 PCB congeners, DDE, and HCB, levels above the limit of quantitation (LOQ) 
were observed in all samples. Levels above the LOQ were observed in only 7/150 samples for 
DDT and 35/150 for BDE-47. Associations between POP measures and covariates were 
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determined among controls (Table 2) in order to assess these associations in the general 
population. The only covariate showing a consistent significant association with POP measures 
was birth year; later birth year was associated with lower levels of these POPs. DDE levels were 
significantly higher (p=0.02) among control mothers who experienced a prior pregnancy, and 
showed a marginally significant (p=0.06) linear association with maternal age. 
Mean levels of none of the pollutants differed significantly between cases and controls. 
However, 90
th
 percentile levels were greater in cases for DDE, HCB and all PCBs (not shown; 
differences in the proportion >90
th
 percentile for cases versus controls that were not statistically 
significant). DDE was minimally correlated with other pollutants (|r|<0.1). For HCB and total 
PCBs, r=0.76.  The correlation between total PCBs and individual congeners ranged from 0.85 
(PCB-118) to 1.00 (PCB-153); for total PCBs and composite TEQ measures, correlation ranged 
from 0.91 (TEQ-dioxin) to 1.00 (NEQ).  
In unadjusted models, most ORs were above 1.0; however, given the small numbers of 
exposed subjects, all CIs were wide and included 1.0. The highest observed ORs (95% CI; p-
value) were for PCB-138: 2.25 (0.69, 7.31; 0.18), PCB NEQ: 2.20 (0.76, 6.33; 0.14), total PCBs: 
2.00 (0.68, 5.85; 0.21), and DDE: 2.00 (0.60, 6.64; p=0.26). ORs (95% CI; p-value) for total 
PCBs >90
th
 percentile were 1.91 (0.57, 6.39; p=0.29) for total PCBs, 0.89 (0.28, 2.76; p=0.83) 
for HCB, and 1.79 (0.51, 6.21; p=0.36) for DDE (Table 3). 
 
4. Discussion 
In this pilot study, we measured levels of 10 POPs in archived maternal serum samples 
corresponding to 75 cases with autism and 75 matched controls born in Finland between 1991 
and 2000. We first demonstrated that 6 PCB congeners, DDE and HCB are quantifiable in these 
archived serum samples, with DDT and BDE-47 quantified in a limited number of samples.  
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We explored associations of POP levels with potential confounding variables among 
controls. Factors previously found to be associated with higher levels of adipose PCBs in a 
Finnish general population included older age, lactation history, geographic area, and frequency 
of fish consumption (Kiviranta et al., 2005). In the present study, total PCBs, HCB and DDE 
levels all decreased significantly with later year of birth, which is indicative of the time of serum 
sampling. This is consistent with the interpretation that cross-sectional associations between 
higher levels of POPs including PCBs and older age was driven by decreased environmental 
exposure over time (Kiviranta et al., 2005).  The concurrent temporal trends of increasing autism 
diagnoses and decreasing POP exposures, in our view, should not necessarily be taken as 
evidence against a potential association. Increased rates of autism diagnoses may have many 
causes (Fombonne, 2002), including increased awareness, changes in diagnostic criteria, and 
increases in other environmental exposures. 
The maternal POP levels observed here were similar to those of certain other populations 
where associations with other neurodevelopmental disorders have been observed. Using 
correction factors previously developed to facilitate comparison across 10 studies of PCBs and 
neurodevelopment from North America and Europe (Longnecker et al., 2003), we estimated a 
median of 57 ng/g lipid for PCB-153 in controls from the present study. This was on the lower 
end of the distribution, but well within the range of 30-450 ng/g lipid PCB-153 reported among 
those 10 studies, which had sample collections ranging from 1959-1998. Our median level was 
closest to those observed in studies of populations from the U.S. in North Carolina (Rogan et al., 
1986), New York (Darvill et al., 2000), and Massachusetts (Korrick et al., 2000). In each of these 
three studies, significant associations have been observed between prenatal PCB exposure levels 
and decrements in neurodevelopmental measures, including, for example, hypotonicity and 
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hyporeflexia (Rogan et al., 1986), attention-related measures (Sagiv et al., 2008) on the Neonatal 
Behavioral Assessment Scale in newborn infants; and intelligence scores on the Fagan Test of 
Infant Intelligence at 6 and 12 months (Darvill et al., 2000).  
Cases with autism in this population have numerically higher percentages of observations 
above the 90
th
 percentile of control distributions for some maternal POPs, suggesting there may 
be a threshold for some pollutants above which higher levels are associated with increased risk 
of autism. Although these associations were not statistically significant in this small study, total 
PCBs at or above the 90
th
 percentile were associated with an odds ratio for autism of 1.91 (95% 
CI, (0.57, 6.39)).   
The strengths of this study include biomarker-based exposure assessments using archived 
maternal serum samples during pregnancy. The subsample of subjects in this study were drawn 
from the FiPS-A, based on a large, population-based national birth cohort including all childhood 
autism cases diagnosed in Finland assessed through psychiatric registries. This population-based 
design reduces the chance of selection bias in the study. The register diagnosis of childhood 
autism has been validated by directly administered ADI-R interviews.  Finally, data on potential 
confounders available through population registers were used for matching and analysis of 
relationships between exposures and outcome. 
We note potential limitations. Since the sample size was limited, a larger study will be 
required to determine whether maternal POP exposure in the upper decile is significantly 
associated with autism in this population. It is also possible that controls were matched to cases 
more closely than necessary to address confounding, thereby decreasing observed differences in 
exposure levels between groups, or that an unmeasured confounder biased the observed 
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association. However, it remains that correlation does not equal causation, and the absence of 
observed correlation does not imply the absence of causation. 
 In conclusion, we showed that POPs are present at detectable levels in prenatal serum 
samples from FiPS-A study subjects. This pilot study suggests that qualitatively higher levels of 
total PCBs may be associated with risk of childhood autism; however, a larger study will be 
required to substantiate this finding given the lack of statistical significance. A larger study 
would also allow subgroup analyses, for example, by child sex. Future studies should also 
address issues of multiple comparisons among correlated exposures, using methods such as 
semi-Bayes hierarchical models (Greenland and Poole, 1994). The identification of 
environmental risk factors for autism may have substantial public health importance given their 
potential modifiability. Despite declining levels over time, 6 PCB congeners, DDE and HCB 
were still detected in 100% of the Finnish samples tested; additionally, a nationally-
representative study from the United States found detectable levels of PCBs, DDE, HCB and 
BDE-47 in 96-100% of samples from pregnant and non-pregnant women of childbearing age in 
2003-2004 (Woodruff et al., 2011).  While tens of thousands of industrial chemicals remain in 
use, information on their potential neurodevelopmental effects is absent for the vast majority 
(Grandjean and Landrigan, 2006). In our view, this study may represent an important initial step 
towards investigating environmental risk factors for autism. 
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Table 1. Demographic characteristics for 75 subjects with childhood autism and 75 
matched controls. 
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Characteristic Autism 
(N=75) 
Controls (N=75) 
 Mean (sd) Mean (sd) 
Birth year 1995 (2.6) 1995 (2.7) 
Maternal age 31.3 (4.1) 30.7 (3.7) 
Paternal age 32.4 (5.6) 32.4 (5.7) 
   
 % % 
Male 84% 84% 
   
Urban (>50,000 inhabitants)
a
  80% 79% 
Rural (<=50,000 inhabitants)
a 
20% 21% 
   
Previous pregnancies >=1 29% 21% 
Socioeconomic status
b 
  
     Upper white collar 33% 28% 
     Lower white collar 43% 51% 
     Blue collar 13% 13% 
     Other 10% 7% 
a
data missing for n=1 observation (cases), percentages calculated out of non-missing values. 
b
data missing for 8 cases and 8 controls, percentages calculated out of non-missing values. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Associations of subject characteristics with persistent organic pollutant levels 
among 75 controls. 
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  Total PCBs
a 
ln(pg/ml) 
HCB
a 
ln(pg/ml) 
DDE
a 
ln(pg/ml) 
 N Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value 
Maternal age        
25-29 39 6.93 (0.48) 0.41 5.05 (0.40) 0.90 6.76 (0.71) 0.16
b 
30-34 22 7.06 (0.40)  5.02 (0.37)  6.95 (0.75)  
35+ 14 7.10 (0.56)  5.01 (0.41)  7.25 (1.16)  
Paternal age        
25-29 25 6.97 (0.53) 0.54 5.06 (0.42) 0.84 6.77 (0.91) 0.44 
30-34 29 7.00 (0.44)  5.04 (0.37)  6.84 (0.61)  
35-39 14 6.94 (0.50)  4.95 (0.41)  7.18 (1.20)  
40+ 7 7.25 (0.35)  5.06 (0.38)  7.09 (0.30)  
Birth year        
1991-1993 23 7.27 (0.45) <0.001
c 
5.32 (0.32) <0.001
b 
7.19 (0.78) 0.01
b 
1994-1996 25 7.01 (0.45)  5.03 (0.36)  7.04 (0.85)  
1997-2000 27 6.77 (0.40)  4.80 (0.31)  6.54 (0.74)  
Infant sex        
Male 63 7.01 (0.49) 0.66 5.02 (0.39) 0.53 6.96 (0.85) 0.21 
Female 12 6.95 (0.42)  5.10 (0.43)  6.63 (0.68)  
Geographic        
Urban 59 7.01 (0.47) 0.88 5.01 (0.42) 0.75 6.94 (0.86) 0.48 
Rural 16 6.99 (0.49)  5.04 (0.38)  6.77 (0.74)  
Previous pregnancies       
None 58 6.99 (0.44) 0.89 5.02 (0.35) 0.75 6.77 (0.65) 0.02 
One or more 15 6.97 (0.57)  4.99 (0.49)  7.31 (1.26)  
Socioeconomic status       
Upper white collar 19 7.14 (0.52) 0.35 5.11 (0.37) 0.75 6.99 (0.69) 0.57 
Lower white collar 34 7.01 (0.41)  5.00 (0.34)  6.87 (0.74)  
Blue collar 9 6.93 (0.43)  5.03 (0.39)  6.71 (0.77)  
Other 5 6.75 (0.44)  4.96 (0.33)  6.55 (0.48)  
a
PCBs, polychlorinated biphenyls; HCB, hexachlorobenzene; DDE, 
dichlorodiphenyldichloroethylene. Total PCBs calculated as the sum of 6 congeners (PCB-118, 
PCB-138, PCB-153, PCB-156, PCB-170, and PCB-180). 
b
Test for linear trend, p=0.06. 
c
Test for linear trend, p<0.01. 
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Table 3: Comparison between childhood autism cases and controls with persistent organic 
pollutant levels at or above the 90
th
 percentiles of control distributions. 
Pollutant n>90
th
 
percentile 
(vs. n=8 
controls) 
OR
a
 (95% CI) OR
b
 (95% CI)
 
   
HCB 10 1.29 (0.48, 3.45) 0.89 (0.28, 2.76) 
DDE 12 2.00 (0.60, 6.64) 1.79 (0.52, 6.21) 
PCB-118 8 1.00 (0.32, 3.10)  
PCB-138 13 2.25 (0.69, 7.31)  
PCB-153 12 1.80 (0.60, 5.37)  
PCB-156 13 1.83 (0.68, 4.96)  
PCB-170 12 1.67 (0.61, 4.59)  
PCB-180 13 1.83 (0.68, 4.96)  
Total PCBs 13 2.00 (0.68, 5.85) 1.91 (0.57, 6.39) 
TEQ dioxin 11 1.75 (0.51, 5.98)  
TEQ thyroid 12 1.80 (0.60, 5.37)  
NEQ 13 2.20 (0.76, 6.33)  
a
Odds ratios from unadjusted conditional logistic regression model comparing childhood autism 
cases and matched controls. 
b
Odds ratios from conditional logistic regression model comparing childhood autism cases and 
matched controls; mutually adjusted for other pollutants in column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
